Traduction de «CNS drug » (Anglais → Français) :

central nervous system drug [ CNS drug | central nervous system agent | CNS agent ]

drug addiction [ drug abuse | drug-taking | fight against drugs | drug addicts(UNBIS) ]

EU Action Plan on Drugs | EU Action Plan to Combat Drugs | EU Drugs Action Plan | European Union Action Plan on Drugs | European Union Action Plan to Combat Drugs | European Union Drugs Action Plan

European Monitoring Centre for Drugs and Drug Addiction [ EMCDDA [acronym] European Monitoring Centre for Drugs ]

drug traffic [ drug trafficking | narcotics traffic | Drugs economy(STW) ]

Global Air Navigation Plan for CNS/ATM Systems [ Global Co-ordinated Plan for Transition to the ICAO CNS/ATM Systems | Global Plan | global co-ordinated plan for transition to the CNS/ATM systems | Global Co-ordinated Plan | Global Co-ordination Plan for Transition to the ICAO CNS/ATM Systems | Global CNS/ATM Tra ]

CNS, Endocrine and Antiparasitic Drugs Division

WHO CNS tumor grading system

O/E - CNS deficit

[1] The eleven general aims of the Strategy are to: (a) ensure that drugs remains a top priority for the EU; (b) ensure that actions are evaluated; (c) continue the balanced approach to drugs; (d) give greater priority to drug prevention, demand reduction and the reduction of the adverse consequences of drug use; (e) reinforce the fight against drug trafficking and to step up police cooperation between Member States; (f) encourage multi-agency cooperation and the involvement of civil society; (g) use to the full the possibilities offered by the Amsterdam Treaty, particularly Article 31 e) on minimum rules on drug trafficking; (h) ...[+++]ensure collection and dissemination of reliable and comparable data on drugs in the EU; (i) progressively integrate the applicant countries and to intensify international cooperation; (j) promote international cooperation, based on the UNGASS principles; and (k) emphasise that implementation of the strategy will require appropriate resources.

[2] The eleven general aims of the Strategy are to: (a) ensure that drugs remains a top priority for the EU; (b) ensure that actions are evaluated; (c) continue the balanced approach to drugs; (d) give greater priority to drug prevention, demand reduction and the reduction of the adverse consequences of drug use; (e) reinforce the fight against drug trafficking and to step up police co-operation between Member States; (f) encourage multi-agency co-operation and the involvement of civil society; (g) use to the full the possibilities offered by the Amsterdam Treaty, particularly Article 31 e) on minimum rules on drug trafficking; (h ...[+++]) ensure collection and dissemination of reliable and comparable data on drugs in the EU; (i) progressively integrate the applicant countries and to intensify international co-operation; (j) promote international co-operation, based on the UNGASS principles; and (k) emphasise that implementation of the strategy will require appropriate resources.

In the field of drug demand reduction, the objective of the EU Drugs Strategy 2013-20 is to contribute to the measurable reduction of the use of illicit drugs, to delay the age of onset, to prevent and reduce problem drug use, drug dependence and drug-related health and social risks and harms through an integrated, multidisciplinary and evidence-based approach, and by promoting and safeguarding coherence between health, social and justice policies.

It recasts the Council Regulation (EEC) No 302/93 on the establishment of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) to extend its role to the new trends in drug use, especially poly-drug use (where illicit drugs are taken in combination with legal drugs or medication).